POTENTIAL PITFALLS ON THE ROAD TO AN EFFECTIVE HIV VACCINE

被引：20

作者：

SCHWARTZ, DH

机构：

[1] Dept of Immunology and Infectious Diseases, Johns Hopkins University School of Hygiene and Public Health, Baltimore, MD 21205

来源：

IMMUNOLOGY TODAY | 1994年 / 15卷 / 02期

关键词：

D O I：

10.1016/0167-5699(94)90133-3

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Experimental-vaccines for AIDS prophylaxis are being tested in larger and higher-risk populations. Here, David Schwartz, an advocate of HIV-vaccine research and development, highlights some of the concerns that have been voiced about this strategy and presents a simple mathematical model that considers the drawbacks to vaccine-induced expansion of HIV-specific CD4+ T cells.

引用

页码：54 / 57

页数：4

共 29 条

[1] HIGH TITERS OF CYTOPATHIC VIRUS IN PLASMA OF PATIENTS WITH SYMPTOMATIC PRIMARY HIV-1 INFECTION [J].

CLARK, SJ ;

SAAG, MS ;

DECKER, WD ;

CAMPBELLHILL, S ;

ROBERSON, JL ;

VELDKAMP, PJ ;

KAPPES, JC ;

HAHN, BH ;

SHAW, GM .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :954-960

[2]

CLERICI M, 1992, BLOOD, V80, P2196

[3] A T(H)1-]T(H)2 SWITCH IS A CRITICAL STEP IN THE ETIOLOGY OF HIV-INFECTION [J].

CLERICI, M ;

SHEARER, GM .

IMMUNOLOGY TODAY, 1993, 14 (03) :107-110

[4] TRANSIENT HIGH-LEVELS OF VIREMIA IN PATIENTS WITH PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].

DAAR, ES ;

MOUDGIL, T ;

MEYER, RD ;

HO, DD .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :961-964

[5] MASSIVE COVERT INFECTION OF HELPER T-LYMPHOCYTES AND MACROPHAGES BY HIV DURING THE INCUBATION PERIOD OF AIDS [J].

EMBRETSON, J ;

ZUPANCIC, M ;

RIBAS, JL ;

BURKE, A ;

RACZ, P ;

TENNERRACZ, K ;

HAASE, AT .

NATURE, 1993, 362 (6418) :359-362

[6]

GARDNER M, 1992, 5TH NAT COOP VACC DE

[7] COMMON EPITOPE IN HUMAN IMMUNODEFICIENCY VIRUS (HIV) I-GP41 AND HLA CLASS-II ELICITS IMMUNOSUPPRESSIVE AUTOANTIBODIES CAPABLE OF CONTRIBUTING TO IMMUNE DYSFUNCTION IN HIV I-INFECTED INDIVIDUALS [J].

GOLDING, H ;

SHEARER, GM ;

HILLMAN, K ;

LUCAS, P ;

MANISCHEWITZ, J ;

ZAJAC, RA ;

CLERICI, M ;

GRESS, RE ;

BOSWELL, RN ;

GOLDING, B .

JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (04) :1430-1435

[8] IDENTIFICATION OF HOMOLOGOUS REGIONS IN HUMAN IMMUNODEFICIENCY VIRUS-I GP41 AND HUMAN MHC CLASS-II BETA-1 DOMAIN .1. MONOCLONAL-ANTIBODIES AGAINST THE GP41-DERIVED PEPTIDE AND PATIENTS SERA REACT WITH NATIVE HLA CLASS-II ANTIGENS, SUGGESTING A ROLE FOR AUTOIMMUNITY IN THE PATHOGENESIS OF ACQUIRED IMMUNE-DEFICIENCY SYNDROME4 [J].

GOLDING, H ;

ROBEY, FA ;

GATES, FT ;

LINDER, W ;

BEINING, PR ;

HOFFMAN, T ;

GOLDING, B .

JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (03) :914-923

[9] LYMPHOCYTE PROLIFERATIVE RESPONSES FOLLOWING IMMUNIZATION WITH HUMAN-IMMUNODEFICIENCY-VIRUS RECOMBINANT GP160 [J].

GORSE, GJ ;

BELSHE, RB ;

NEWMAN, FK ;

FREY, SE .

VACCINE, 1992, 10 (06) :383-388

[10] VACCINATION OF VACCINIA-NAIVE ADULTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP160 RECOMBINANT VACCINIA VIRUS IN A BLINDED, CONTROLLED, RANDOMIZED CLINICAL-TRIAL [J].

GRAHAM, BS ;

BELSHE, RB ;

CLEMENTS, ML ;

DOLIN, R ;

COREY, L ;

WRIGHT, PF ;

GORSE, GJ ;

MIDTHUN, K ;

KEEFER, MC ;

ROBERTS, NJ ;

SCHWARTZ, DH ;

AGOSTI, JM ;

FERNIE, BF ;

STABLEIN, DM ;

MONTEFIORI, DC ;

LAMBERT, JS ;

HU, SL ;

ESTERLITZ, JR ;

LAWRENCE, DN ;

KOFF, WC .

JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (02) :244-252

← 1 2 3 →